Primary cerebral neuroblastoma is a rare malignant tumor encountered most commonly in children. The radiological features of this entity are variable and rarely reported. The diffusion-weighted imaging (DWI) findings have not previously reported. We describe serial DWI and conventional MRI in a case of primary cerebral neuroblastoma to assess the imaging features and the role of DWI for monitoring chemoradiotherapy response.
HortenBCRubinsteinLJ. Primary cerebral neuroblastoma: a clinicopathological study of 35 cases. Brain. 1976; 99 (4): 735–756. doi: 10.1093/brain/99.4.735.
2.
LouisDNOhgakiHWiestlerOD. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007; 114 (2): 97–109. doi: 10.1007/s00401-007-0243-4.
3.
D'AmbrosioALyoJKYoungRJ. Imaging of metastatic CNS neuroblastoma. Am J Roentgenol. 2010; 194 (5): 1223–1229. doi: 10.2214/AJR.09.3203.
4.
DavisPCWichmanRDTakeiY. Primary cerebral neuroblastoma: CT and MR findings in 12 Cases. Am J Neuroradiol. 1990; 11 (1): 115–120.
5.
GahrNDargeKHahnG. Diffusion-weighted MRI for differentiation of neuroblastoma and ganglioneuroblastoma/ganglioneuroma. Eur J Radiol. 2011: 79 (3): 443–446. doi: 10.1016/j.ejrad.2010.04.005.
6.
UhlMAltehoeferCKontnyU. MRI-diffusion imaging of neuroblastomas: first reports and correlation to histology. Eur Radiol. 2002; 12 (9): 2335–2338.
7.
HumphriesPDSebireNJSiegelMJ. Tumors in pediatric patients at diffusion-weighted MR imaging: apparent diffusion coefficient and tumor cellularity. Radiology. 2007; 245 (3): 848–854. doi: 10.1148/radiol.2452061535.
8.
YamasakFKurisuKSatohK. Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology. 2005; 235 (3): 985–991. doi: 10.1148/radiol.2353031338.
9.
MoffatBAChenevertTLLawrenceTS. Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci USA.2005; 102 (15): 5524–5529. doi: 10.1073/pnas.0501532102.
10.
HamstraDARehemtullaARossBD. Diffusion magnetic resonance imaging: a biomarker for treatment response in oncology. J Clin Oncol. 2007; 25 (26): 4104–4109. doi: 10.1200/JCO.2007.11.9610.
